Istanbul University Istanbul Medical Faculty; Neurology

Istanbul 34093

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing-Remitting, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors — Running, not enrolling
• Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS) — Stopped early